Telix Pharmaceuticals | TLX - Trade Creditors

Stock Price
14.98
Daily Change
-0.02 -0.13%
Monthly
9.66%
Yearly
-46.48%
Q2 Forecast
14.62

Telix Pharmaceuticals reported AUD71.66M in Trade Creditors for its fiscal semester ending in December of 2025.





Trade Creditors Change Date
Cochlear AUD 281.3M 17.1M Dec/2025
CSL USD 3.17B 290M Dec/2025
Integral Diagnostics AUD 28.28M 17.87M Dec/2023
Mayne Pharma AUD 30.25M 2.99M Jun/2025
Medical Developments International AUD 4.31M 2.18M Dec/2025
Mesoblast USD 33.58M 14.49M Dec/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Pacific Edge NZD 5.45M 2.6M Dec/2025
Paradigm Biopharmaceuticals AUD 4.44M 1.71M Dec/2025
Polynovo AUD 4.9M 2.04M Dec/2025
PYC Therapeutics AUD 9.56M 802.76K Dec/2025
Ramsay Health Care AUD 2.02B 289.9M Dec/2025
ResMed USD 250.41M 16.36M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024